| Identification | |
| Name: | Miltefosine |
| Synonyms: | D 18506;FOS-Choline16;Hexadecylphosphocholine;Hexadecylphosphorylcholine;Miltex;NSC 605583;N-Hexadecylphosphocholine;Ethanaminium,2-[[(hexadecyloxy)hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt; |
| CAS: | 58066-85-6 |
| Molecular Formula: | C21H46NO4P |
| Molecular Weight: | 407.568001 |
| InChI: | InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3 |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 232-234ºC |
| Water Solubility: | Insoluble in water.Soluble in methanol. |
| Solubility: | Insoluble in water.Soluble in methanol. |
| Appearance: | white to off-white powder |
| Specification: |
N-Hexadecylphosphorylcholine (CAS NO.58066-85-6), its Synonyms are 2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt ; Miltefosine ; Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI) ; Hexadecylphosphocholine ; Hexadecylphosphorylcholine ; Miltefosina ; Choline hydroxide, hexadecyl hydrogen phosphate, inner salt ; Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt . |
| Usage: | A phospholipid drug with antineoplastic and antiprotozoal/antifungal properties, also acts as an Akt inhibitor, and under investigation as a potential therapy against HIV infection. |
| Safety Data | |
 |
|
